Track topics on Twitter Track topics that are important to you
Molecular Simulations Inc., a subsidiary of Pharmacopeia, Inc., is a leading provider of molecular modeling, simulation, and informatics software to the world’s foremost pharmaceutical, biotechnology, and chemical R&D facilities. Using MSI’s software and services, researchers can organize and analyze scientific data, share biological and chemical information, and develop novel compounds, materials, and processes. MSI employs over 325 people, nearly half of whom are Ph.D. scientists. Company headquarters are in San Diego, California. Major regional operations are in Cambridge, England, and Tokyo, Japan.
Industrial R&D organizations strive to accelerate product discovery and development, reduce costs, improve processes, and address environmental standards. Computer simulation helps to achieve these goals — guiding scientists to new solutions and focusing experiments on the most productive pathways. Molecular simulation is the most fundamental simulation strategy; it allows researchers to predict the structures and properties of chemicals, biological compounds, and materials. MSI’s software combines this technology with high quality graphics visualization and informatics tools that maximize the utility of chemical and genomic databases.
Founded in Science
MSI has established a reputation as the leader in the scientific development and commercial implementation of simulation methodologies. MSI’s commitment to scientific excellence is reflected in its investment in scientific staff. Nearly half of MSI’s staff are Ph.D. scientists who are recognized experts in computational chemistry, biology, physics, and computer science. This scientific background is combined with expertise in software engineering and design. In-house experience is reinforced through close relationship with leading academic institutions, such as the California Institute of Technology, the University of California at Berkeley, Harvard University, and the University of Yale, Cambridge, and York.
Partnership and Services
Development, validation, and application of MSI products are conducted in close collaboration with users. A hallmark of this collaboration is MSI’s Consortia, application-focused groups of industrial researchers, leading academics, and MSI staff who develop strategies to solve problems in specific areas of industrial relevance. MSI sponsors Consortia in Catalysis and Sorption, Pharmaceutical Development, Polymers, Potential Energy Functions, and Combinatorial Chemistry.
About Pharmacopeia, Inc.
Pharmacopeia is a leader in drug discovery combining three platform technologies: informatics, small molecule combinatorial chemistry, and high-throughput screening. Through its wholly-owned subsidiary, Molecular Simulations Inc. (MSI), Pharmacopeia develops and commercializes molecular modeling, simulation, and informatics software and services. Using ECLiPS, its proprietary combinatorial chemistry technology, Pharmacopeia has generated more than 4.2 million diverse, easily identifiable, small molecules. Pharmacopeia tests these molecules using state-of-the-art high-throughput screening. These technologies are integrated to support the following businesses:
1) selling predictive modeling, information management, and structure-based design software to the life and materials science marketplace,
2) licensing collections of compounds to pharmaceutical companies for evaluation in multiple drug discovery programs,
3) identifying and optimizing lead compounds for specific targets provided by customers, and
4) licensing drug development candidates developed in Pharmacopeia’s internal drug discovery programs to pharmaceutical companies.
9685 Scranton Road
United States of America
Phone: 619 458 9990
Fax: 619 458 0136
NewsThe same simulations strongly suggest that the metal cannot be strengthened forever.Contributed Author:
Supramolecular heterostructures have been formed by the sequential deposition of two molecular layers with different symmetries and lattice constants — one consisting of carboxylic acid, the other o...
Ordinarily, the strength and plasticity properties of a metal are defined by dislocations—line defects in the crystal lattice whose motion results in material slippage along lattice planes. Dislocat...
Researchers at the Universities of Vienna and Göttingen have succeeded in developing a method for predicting molecular infrared spectra based on artificial intelligence. These chemical "fingerprints"...
(University of Oregon) Computer simulations of electrical charges sent to retinal implants based on fractal geometry have University of Oregon researchers moving forward with their eyes focused on bio...
Theoretical physicists led by Professor Kurt Binder and Dr. Arash Nikoubashman at Johannes Gutenberg University Mainz in Germany have used computer simulations to study the arrangement of stiff polyme...
(PLOS) New statistical simulations suggest that Northern Hemisphere flu pandemics are most likely to emerge in late spring or early summer at the tail end of the normal flu season, according to a new ...
SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...
Reactive molecular dynamics (MD) simulations are a versatile tool which allow for studying reaction pathways and rates simultaneously. However, most reactions will be observed only a few times in such...
p38α is a Ser/Thr protein kinase involved in a variety of cellular processes and pathological conditions, which makes it a promising pharmacological target. Although the activity of the enzyme is hig...
Antibodies and T-cell receptors are important proteins of the immune system that share similar structures. Both contain variable and constant regions. Insight into the dynamics of their binding can be...
Principal component analysis is a technique widely used for studying the movements of proteins using data collected from molecular dynamics simulations. In spite of its extensive use the technique has...
ADP-ribosylhydrolases (ARH1, ARH2 and ARH3) are a family of enzymes to catalyze ADP-ribosylation, a reversible and covalent post-translational modification (PTM). There are four phosphorylated sites (...
Communication and teamwork failures are the leading causes of errors in healthcare settings. In situ mock code simulations are a potential means to train team-based skills using simulatio...
The purpose of this study is to determine ticagrelor combining with low molecular weight heparin is effective and safe during PCI or not.
The investigators developed 18F-MPG as a targeted molecular imaging agent for noninvasive and repeatable detecting EGFR-activating mutational status.
The aim of the planned research project is to find out the clinical significance of molecular genetic analyzes in gynecological malignomas. In particular, it will be investigated how the k...
CFD simulations in this study provide detailed hemodynamics information, which cannot be obtained from cardiac images alone. We hypothesize that our proposed simulations will provide stron...
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research ...
EPS serves the needs of emergency response organizations by helping them prepare for, respond to, and recover from emergencies.We do this through a unique program of thought provoking action based tra...
Founded in 2003, Kognito is a leader in immersive learning experiences that drive positive change in health behaviors. Kognitoâs award-winning online and mobile simulations w...
CCG (www.chemcomp.com) is a leading supplier of software solutions for Life Sciences. CCGâs drug discovery software platform is the Molecular Operating Environment (MO...
PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...
We have published hundreds of Molecular Simulations Incorporated news stories on BioPortfolio along with dozens of Molecular Simulations Incorporated Clinical Trials and PubMed Articles about Molecular Simulations Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Molecular Simulations Incorporated Companies in our database. You can also find out about relevant Molecular Simulations Incorporated Drugs and Medications on this site too.
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...